These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3590096)

  • 1. Effect of MD-805 on plasminogen activator release by thrombin from isolated perfused dog leg.
    Hijikata-Okunomiya A; Kitaguchi H; Hirata M
    Thromb Res; 1987 Mar; 45(5):699-702. PubMed ID: 3590096
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of thrombin on plasminogen activator release from isolated perfused dog leg.
    Kitaguchi H; Hijikata A; Hirata M
    Thromb Res; 1979; 16(3-4):407-20. PubMed ID: 516002
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of proteases on plasminogen activator release from isolated perfused dog leg.
    Hijikata A; Hirata M; Kitaguchi H
    Thromb Res; 1980 Dec 1-15; 20(5-6):521-31. PubMed ID: 7015552
    [No Abstract]   [Full Text] [Related]  

  • 4. A further study on plasminogen activator release by vasoactive agents in the isolated perfused dog leg.
    Hirata M; Kitaguchi H; Funahara Y
    Kobe J Med Sci; 1980 Jun; 26(2):101-8. PubMed ID: 7190627
    [No Abstract]   [Full Text] [Related]  

  • 5. Variation in activities of non-plasmin fibrinolytic proteinase and plasminogen-activator in the lung and spleen induced by bacterial endotoxin in rats with special reference to the effects of MD-805.
    Okamoto U; Nagamatsu Y; Horie N; Yamamoto J; Sasaki K
    Thromb Haemost; 1985 Jun; 53(3):323-7. PubMed ID: 3901390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator release with experimental vasoconstrictions in the isolated perfused dog leg.
    Izaki S
    Kobe J Med Sci; 1978 Mar; 24(1):1-16. PubMed ID: 713439
    [No Abstract]   [Full Text] [Related]  

  • 7. Perfused rat hindlegs. A model to study plasminogen activator release.
    Emeis JJ
    Thromb Res; 1983 May; 30(3):195-203. PubMed ID: 6683431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluidity of cadaveric blood after sudden death: Part II. Mechanism of release of plasminogen activator from blood vessels.
    Takeichi S; Wakasugi C; Shikata I
    Am J Forensic Med Pathol; 1985 Mar; 6(1):25-9. PubMed ID: 4039106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of plasminogen activator from isolated perfused dog heart.
    Matsubara F; Sueishi K; Ishii Y; Tanaka K
    Thromb Haemost; 1985 Feb; 53(1):126-9. PubMed ID: 4039471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental studies of the liberation of plasminogen activator by DDAVP].
    Jablonowski C; Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):567-74. PubMed ID: 6083928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of alpha-NAPAP on thrombin-induced release of plasminogen activator.
    Klöcking HP; Hoffmann A; Markwardt F
    Thromb Res; 1988 Oct; 52(1):71-3. PubMed ID: 3201399
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin.
    Li N; He S; Blombäck M; Hjemdahl P
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):407-13. PubMed ID: 17138937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular fibrinolytic activity after thrombin perfusion in the rat.
    Sraer JD; Delarue F; Dard S; De Seigneux R; Morel-Maroger L; Kanfer A
    Lab Invest; 1975 Apr; 32(4):515-7. PubMed ID: 123973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-induced vasoconstriction in isolated cerebral arteries and the influence of a synthetic thrombin inhibitor.
    Nakamura K; Hatano Y; Mori K
    Thromb Res; 1985 Dec; 40(5):715-20. PubMed ID: 4089836
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of endogenous plasminogen activator-induced thrombolysis by argatroban and APC and its control by TAFI, measured in an arterial thrombolysis model in vivo using rat mesenteric arterioles.
    Hashimoto M; Yamashita T; Oiwa K; Watanabe S; Giddings JC; Yamamoto J
    Thromb Haemost; 2002 Jan; 87(1):110-3. PubMed ID: 11848438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the release of plasminogen activator from the isolated rat lung by serine proteinases.
    Klöcking HP; Jablonowski C; Markwardt F
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):375-9. PubMed ID: 6172878
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological observations of plasminogen activator release caused by vasoactive agents in isolated perfused pig ears.
    Nakajima K
    Thromb Res; 1983 Jan; 29(2):163-74. PubMed ID: 6189238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dilazep on fibrinolytic system in animals. II. Enhancing effect of dilazep on plasminogen activator release in the isolated perfused pig ear.
    Nakajima K
    J Pharmacobiodyn; 1982 May; 5(5):363-9. PubMed ID: 6889645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative analysis of the effect of alpha-thrombin and trypsin on the state of the anticoagulating system].
    Strukova SM; Mitroshina TN; Kudriashov BA
    Fiziol Zh SSSR Im I M Sechenova; 1983 Nov; 69(11):1467-72. PubMed ID: 6686161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of phenol ring polymers on the release of plasminogen activators].
    Klöcking HP; Klöcking R; Helbig B
    Farmakol Toksikol; 1984; 47(1):93-5. PubMed ID: 6538511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.